Targeted communication, such as risk-stacking to improve risk-awareness, harmonized eligibility criteria, and co-administration, may help overcome remaining vaccination barriers in high-risk individuals.
Abstract
ABSTRACT Seasonal influenza and COVID-19 vaccination in high-risk individuals prevent disease, disability, and death. Nevertheless, many high-income countries continue to experience suboptimal vaccine coverage. We therefore aimed to identify the remaining vaccination barriers in these settings. We recruited patients seeking emergency department care at a hospital in northern Sweden. Using semi-structured interviews and medical records, we collected high-resolution individual-level data, and linked community-level determinants from national registers. Logistic regression was used to calculate odds ratios (OR) and adjusted odds ratios (aOR) for determinants associated with influenza and COVID-19 vaccination. We included 600 patients of whom 450 were eligible for both vaccines. Coverage among eligible individuals was 52.0% for influenza and 54.2% for COVID-19. Co-administration of both vaccines was high (OR 55.33, 95% CI: 30.86–99.22). Individual-level determinants associated with lower vaccine uptake included male biological sex (aOR: 0.57, 95% CI: 0.37–0.88, younger age (aOR: 0.50, 95% CI: 0.41–0.61), smoking (aOR: 0.43, 95% CI: 0.18–1.02), reduced independence (aOR: 0.59, 95% CI: 0.31–1.10), and age-only eligibility (aOR 0.41, 95% CI: 0.19–0.86). In multimorbid individuals, meeting more eligibility criteria showed no significant association with higher uptake (aOR: 1.14, 95% CI: 0.93–1.39). Finally, we noted only limited influence of community-level determinants. In conclusion, vaccine uptake for influenza and COVID-19 was primarily associated with individual-level determinants, whereas community-level showed little impact. Targeted communication, such as risk-stacking to improve risk-awareness, harmonized eligibility criteria, and co-administration, may help overcome remaining vaccination barriers in high-risk individuals.
Targeted communication, such as risk-stacking to improve risk-awareness, harmonized eligibility criteria, and co-administration, may help overcome remaining vaccination barriers in high-risk individuals.
Lucas Grape, Wilma Persson, Adam Sergejev et al.· 0 citations
In this primary care survey, influenza vaccination during the 2022-2023 season was primarily associated with prior influenza vaccination history, suggesting persistence of vaccination practices over time and targeted strategies that reinforce continuity and encourage initiation among previously unvaccinated adults coul...
S. Mafi, A. Billo, M. Durieux et al.· BMC Public Health· 0 citations
The findings highlight recent attitudes and barriers to influenza and COVID-19 vaccination among the FluSurvey cohort, which may inform approaches to improve vaccination coverage in the population.
L. Adams, C. Watson, R. E. Green et al.· medRxiv· 0 citations
Across all three vaccines, uptake remains below national targets in people living with HIV in Ontario, particularly for those at highest risk of severe respiratory infections, and interventions that address predisposing, enabling, and need factors associated with vaccine uptake may help improve access and promote vacci...
C. Chambers, T. Bekele, R. Grewal et al.· Aids and Behavior· 0 citations
It is found that COVID-19 vaccination was protective against Long COVID, and a significant waning of this protection within seven months after vaccination was observed.
Z. Butzin-Dozier, Yunwen Ji, Lin-Chiun Wang et al.· EBioMedicine· 0 citations
Ambulatory children with influenza who were vaccinated experienced less ILI symptom burden compared to those who were not vaccinated against influenza, but vaccination was not associated with symptom duration.
Amanda C Howa, Yu-Wei Zhu, T. McGonigle et al.· Clinical Infectious Diseases· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.